Patriot Financial Group Insurance Agency LLC Purchases 9,502 Shares of The Cooper Companies, Inc. $COO

Patriot Financial Group Insurance Agency LLC grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 118.1% during the first quarter, HoldingsChannel.com reports. The firm owned 17,548 shares of the medical device company’s stock after purchasing an additional 9,502 shares during the period. Patriot Financial Group Insurance Agency LLC’s holdings in Cooper Companies were worth $1,255,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after buying an additional 7,363 shares during the period. First Trust Advisors LP grew its holdings in Cooper Companies by 115.8% during the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after acquiring an additional 73,165 shares during the last quarter. Cresset Asset Management LLC acquired a new position in Cooper Companies in the 2nd quarter valued at approximately $291,000. Cerity Partners LLC increased its position in Cooper Companies by 4.4% in the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after acquiring an additional 757 shares during the period. Finally, Daiwa Securities Group Inc. raised its stake in shares of Cooper Companies by 2.8% during the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after acquiring an additional 973 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on COO shares. Barclays lifted their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. BNP Paribas Exane decreased their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Robert W. Baird cut their target price on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. Finally, The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research report on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $81.31.

Cooper Companies Trading Up 0.5%

NASDAQ:COO opened at $71.39 on Tuesday. The firm’s fifty day moving average is $64.14 and its 200-day moving average is $73.56. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The firm has a market cap of $13.92 billion, a P/E ratio of 60.50, a P/E/G ratio of 1.86 and a beta of 0.88.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.